TABLE 5.
CMV
| 2-Drug | 3-Drug | Total | 2 vs. 3 | Subgroup | |
|---|---|---|---|---|---|
| Overall | 12% | 15% | 14% | NS | |
| + → − | 30% | 47% | 38% | NS | |
| + → + | 3% | 8% | 6% | NS | P < .00001 |
| − → − | 11% | 15% | 13% | NS | |
| − → + | 10% | 7% | 8% | NS |
CMV
| 2-Drug | 3-Drug | Total | 2 vs. 3 | Subgroup | |
|---|---|---|---|---|---|
| Overall | 12% | 15% | 14% | NS | |
| + → − | 30% | 47% | 38% | NS | |
| + → + | 3% | 8% | 6% | NS | P < .00001 |
| − → − | 11% | 15% | 13% | NS | |
| − → + | 10% | 7% | 8% | NS |